September 9, 2011 source: originally published in the San Francisco Business Times Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal. A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and […]Read More
Berger joins as Associate; Lyons joins as Entrepreneur-In-Residence (EIR) Claremont Creek Ventures, a seed and early-stage venture capital firm known for turbocharging the uncommon startup, today announced the addition of two investment professionals who have impressive experience either in the medical sector or in product leadership at early-stage cleantech innovators. Brian Berger, MD, 41, joins […]Read More
July 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]Read More
May 11, 2011 source: Wall Street Journal Health Blog Public Education and Gene Testing to Improve Medication Adherence There are tons of reasons why people don’t take the medications they’ve been prescribed, including side effects, cost and complicated drug regimens. A couple of different approaches to improving adherence are in the news today. The first […]Read More
April 5, 2011 source: Gene Security Network press release Gene Security Network (GSN) welcomes the birth of the first baby to be born following the use of GSN’s novel Parental SupportTM technology for single gene preimplantation genetic diagnosis (PGD) and concurrent 24-chromosome screening. This test allows couples who are at risk to have children […]Read More
March 25, 2011 source: VentureWire by Timothy Hay AssureRx Health Inc. has raised an $11 million Series B round from Sequoia Capital and Claremont Creek Ventures for its testing system that helps psychiatric patients find the most compatible medications, according to an investor. “This could be one of the biggest diagnostic companies of the decade, […]Read More
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.